Summary
It is important that the stability of reconstituted parenteral antineoplastic agents be established, particularly in the context of ambulatory infusion systems for delivery. The stability of selected agents within each of the five classes of compounds (antimetabolites, alkylating agents, antibiotics, alkaloids and glycosides, and metals) is reviewed from the literature together with additional data from studies carried out using high-performance liquid chromatographic (HPLC) technology in clinically applicable volumes and concentrations for ambulatory infusion. The stability of reconstituted drugs varies from a few minutes (mecloethamine) to many months (FU). Compatibility data on two- and three-drug admixtures of cytotoxic agents are reported for a number of common multidrug regimens. Tabular presentation of the drug-drug compatibilities and incompatibilities is included along with a discussion of the mechanisms for drug-drug interaction. The use of a broad spectrum of compatible cytotoxic drugs is possible, including fluoropyrimidine-, anthracycline-, and platinum-based combinations, providing the capability of carrying out multidrug infusions for 4–7 days in an ambulatory delivery system.
Similar content being viewed by others
Abbreviations
- CBP:
-
carboplatin
- CDDP:
-
cisplatin
- CP:
-
cyclophosphamide
- DTC:
-
decarbazine
- DX:
-
doxorubicin
- D5W:
-
dextrose for injection
- FU:
-
fluorouracil
- FUDR:
-
floxuridine
- IF:
-
ifosfamide
- LV:
-
leucovorin
- MMC:
-
mitomycin C
- MTX:
-
methotrexate
- NS:
-
sodium chloride for injection
- R:
-
Ringer's injection
- SW:
-
sterile water
- VP16:
-
etoposide
References
Adams PS, Haines-Nutt RF, Bradford E, Palmer A, Rowland CB (1987) Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J April 11: 476–478
Allsopp M, Sewell GJ, Rowland C, Riley CM, Schowen RL (1991) The degradation of carboplatin in aqueous solutions containing chloride or other nucleophiles. Int J Pharm 69: 197–210
Anderson N, Lokich J, Bern M, Wallach S, Moore C, Williams D (1989) A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Cancer 63:233–237
Anderson N, Lokich J, Bern M, Wallach S, Moore C, Williams D, Umprayn V (1989) Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. Cancer 63:825–827
Bayoni SM, Al-Badr AA (1989) Fluorouracil. In: Florey K (ed) Analytical profiles of drug substances, vol 18. Academic Press, New York, pp 599–639
Behme RJ, Brooke D, Kensler TT, Scott JA (1988) Incompatibility of ifosfamide with benzyl alcohol preserved bacteriostatic water for injection. Am J Hosp Pharm 45: 627–628
Beijnen JH, Rosing H, Vries PA de, Underberg WJM (1985) Stability of anthracycline antitumor agents in infusion fluids. J Parenter Sci Technol 39: 220–222
Beijnen JH, Houwen OAGJ van der, Underberg WJM (1986) Aspects of the degradation kinetics of doxorubicin in aqueous solution. Int J Pharm 32: 123–131
Beijnen JH, Houwen OAGJ van der, Voskuilen MCH, Underberg WJM (1986) Aspects of the degradation kinetics of daunorubicin in aqueous solution. Int J Pharm 31: 75–82
Beijnen JH, Lingeman H, Van Munster HA, Underberg WJM (1986) Mitomycin antitumour agents: a review of their physico-chemical and analytical properties and stability. J Pharm Biomed Anal 4: 275–295
Beijnen JH, Neef C, Meuwissen OJAT, Rutten JMH, Rosing H, Underberg WJM (1986) Stability of intravenous mixtures of doxorubicin and vincristine. Am J Hosp Pharm 43: 3022–3026
Beijnen JH, Bult A, Underberg WJM (1987) Mitomycin C. In: Florey K (ed) Analytical profiles of drug substances, vol 16. Academic Press. New York, pp 361–401
Beijnen JH, Bult A, Underberg WJM (1988) Mitoxanthrone hydrochloride. In: Florey K (ed) Analytical profiles of drug substances, vol 17. Academic Press, New York, pp 221–258
Beijnen JHM, Vendrig DEMM, Underberg WJM (1988) Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids. J Parenter Sci Technol 43: 84–87
Beijnen JH, Holthuis JJM, Kerkdijk HG, Paalman ACA, Bult A, Underberg WJM (1988) Degradation kinetics of etoposide in aqueous solution. Int J Pharm 41: 169–178
Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL (1981) Stability and compatibility of antitumor agents in glass and plastic containers. Am J Hosp Pharm 38: 1914–1918
Benvenuto JA, Adams SC, Vyas HM, Anderson RW (1987) Pharmaceutical issues in infusion chemotherapy stability and compatibility. In: Lokich J (ed) Cancer chemotherapy by infusion, 1st edn. Precept, Chicago, pp 100–113
Bosanquet AG (1986) Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays: Adriamycin and other antitumour antibiotics. Cancer Chemother Pharmacol 17: 1–10
Brooke D, Bequette RJ, Davis RE (1973) Chemical stability of cyclophosphamide in parenteral solutions. Am J Hosp Pharm 30: 134–137
Carter SK, Crooke ST (1979) Mitomycin C: current status and new developments. Academic Press, New York
Cheung Y-W, Cradock JC, Vishnuvajjala BR, Flora KP (1987) Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions. Am J Hosp Pharm 44: 124–130
Connors KA, Amidon GL, Stella VJ (1986) Chemical stability of pharmaceuticals: a handbook for pharmacists, 2nd edn. J Wiley & Sons New York
Dine T, Luyckx M, Cazin JC, Buenet C, Cazin M, Goudaliez F, Mallevais ML (1991) Stability and compatibility of vinblastine, vincristine, vindesine, and vinorelbine with PVC infusion bags. Int J Pharm 77: 279–285
Dorr RT, Fritz WL (1980) Drug data sheets: Bleomycin sulfate. In: Dorr RT, Fritz WL (eds) Cancer chemotherapy handbook. Elsevier, New York, pp 274–283
Dyvik O, Grislingaas AL, Tonnesen HH, Karlsen J (1986) Methotrexate in infusion solutions — stability test for the hospital pharmacy. J Clin Hosp Pharm 11: 343–348
Hansen J, Kreilgard B, Nielson O, Vege J (1983) Kinetics of degradation of methotrexate in aqueous solution. Int J Pharm 16: 141
Holthuis JJM, Kettens-vandenBosh, Bult A (1989) Etoposide. In: Florey K (ed) Analytical profiles of drug substances. vol 18. Academic Press, New York, pp 121–151
Horton JK, Stevens MFG (1981) A new light on the photodecomposition of the antitumour drug DTIC. J Pharm Pharmacol 33: 808–811
Humphreys A, Marty JJ, Gooey SL, Bourne DWF (1978) Stability of methotrexate in an intravenous fluid. Aust J Hosp Pharm 8: 66–67
Keller JH, Ensminger WD (1982) Stability of cancer chemotherapeutic agents in a totally implantable drug delivery system. Am J Hosp Pharm 39: 1321–1323
Koberda M, Zieske PA, Raghavan NV, Payton RJ (1990) Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers. Am J Hosp Pharm 47: 2528–2529
Lokich J, Anderson N, Bern M, Wallach S, Moore C, Williams D Umprayn V (1988) Combined floxuridine and cisplatin in a fourteen day infusion. Cancer 62: 2309–2312
Lokich J, Anderson N, Bern M, Wallach S, Moore C, Williams D (1989) Etoposide admixed with cisplatin. Cancer 63: 818–821
Lokich J, Bern M, Anderson N, Wallach S, Moore C, Beauchamp K, Williams D (1989) Cyclophosphamide methotrexate, and 5-fluorouracil in a three drug admixture. Cancer 63: 822–824
Mariani EP, Southard BJ, Woolever JT, Erlich RH, Granatek AP (1980) Physical compatibility and chemical stability of cisplatin in various diluents and in large volume parenteral solutions. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin, Current status and new developments. 1st edn. Academic Press, New York, pp 305–316
McElnay JC, Elliott DS, Cartwright-Shamoon J, D'Arcy PF (1988) Stability of methotrexate and vinblastine in burette administration sets. Int J Pharm 47: 239–243
Pont LO, Cheung APK, Lin P (1979) Calcium leucovorin. In: Florey K (ed) Analytical profiles of drug substances, vol 8. Academic press, New York, pp 315–350
Poochikian GK, Cradock JC, Flora KP (1981) Stability of anthracycline agents in four infusion fluids. Am J Hosp Pharm 38: 483–486
Radford JA, Margison JM, Swindell R, Lind MJ, Wilkinson PM, Thatcher N (1990) The stability of ifosfamide in aqeous solution and its suitability for continuous 7-day infusion by ambulatory pumps. Cancer Chemother Pharmacol 26: 144–146
Reynolds DL, Sternson LA, Repta AJ (1981) Clinical analysis for the antineoplastic agent, 1,4-dihydroxy-5,8-bis-2-[(2-hydroxyethyl)-amino]-9,10-anthracenedione in plasma. J Chromatogr 222: 225–230
Riley CM, Sternson LA (1989) Cisplatin. In: Florey K (ed) Analytical profiles of drug substances, vol 14. Academic Press, New York, pp 77–105
Seargeant L, Kobrinsky NL, Sus CJ, Nazeravich DR (1987) In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide. Cancer Treat Rep 71: 1189–1193
Sewell GJ, Riley CM, Rowland CG (1987) The stability of carboplatin in ambulatory continuous infusion regimes. J Clin Pharm Ther 12: 427–432
Smith JA, Morris A, Duafala ME, Bertino JR, Markman M, Kleinberg M (1989) Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administration. Am J Hosp Pharm 46: 985–989
Stella VJ (1987) Chemical and physical bases determining the instability and incompatibility of formulatd injectable drugs. J Parenter Sci Technol 40: 142–163
Stewart CF, Hampton EM (1989) Stability of cisplatin and etoposide in intravenous admixtures. Am J Hosp Pharm 46: 1400–1404
Stewart CF, Fleming R (1990) Compatibility of cisplatin and 5-fluorouracil in 0.9% sodium chloride injection. Am J Hosp Pharm 47: 1373–1377
Tavoloni N, Guarino AM, Berk PD (1980) Photolytic degradation of Adriamycin. J Pharm Pharmacol 32: 860–862
Tomlinson E, Malspeis L (1982) Concomitant adsorption and stability of anthracycline antibiotics. J Pharm Sci 72: 1121–1125
Trissel LA, Kleinman LM, Cradock JC, Davignon JP (1979) Investigational drug information: ifosfamide. Drug Intell Clin Pharm 13: 340–341
Trissel LA, Flora KP, Vishnuvajjala BR, Davignon JP, Quinn FR (1990) NCI Investigational drugs: Pharmaceutical data 1990. National Institutes of Health, Bethesda, Maryland
Trissel LA (1990) Handbook on injectable drugs, 6th edn. American Society of Hospital Pharmacy, Bethesda, Maryland
Vendrig DEMM, Smeets BPGM, Beijnen JH, Houwen OAGJ van der, Holthuis JJM (1988) Degradation kinetics of vinblastine sulphate in aqueous solutions. Int J Pharm 43: 131–138
Vendrig DEMM, Beijnen JH, Houwen OAGJ van der, Holthuis JJM (1989) Degradation kinetics of vincristine sulphate and vindesine sulphate in aqueous solutions. Int J Pharm 50: 189–196
Vincke BJ, Verstraeten AE, El Eini DID, McCarthy TM (1989) Extended stability of 5-fluorouracil and methotrexate solutions in PVC containers. Int J Pharm 54: 181–185
Walker SE, Lau DWC, DeAngelis C, Iazzetta J, Coons C (1980) Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 43: 265–271
Walker SE, Lau DWC, DeAngelis C, Iazzetta J, Coons C (1991) Mitoxantrone stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 44: 143–148
Williams DA (1990) Stability and compatibility of admixtures of antineoplastic drugs. In: Lokich J (ed) Cancer Chemotherapy by infusion, 2nd edn. Precept, Chicago, 7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, D.A., Lokich, J. A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions. Cancer Chemother. Pharmacol. 31, 171–181 (1992). https://doi.org/10.1007/BF00685544
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00685544